Associated Papers
Comprehensive molecular characterization of craniopharyngiomas using whole transcriptome and spatial transcriptomics approaches.
Kert Š et al.
Brain Tumor Pathology, 2025
40634824 (PubMed )
Supplement: 10014_2025_509_MOESM1_ESM.pdf
A Comprehensive Guide to Achieving New York State Clinical Laboratory Evaluation Program Approval for Next-Generation Sequencing Assays.
Galbo PM et al.
The Journal of Molecular Diagnostics : Jmd, 2025
40158885 (PubMed )
Supplement: mmc8.xlsx › Sheet1
Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study.
Zhang H et al.
Oncology Letters, 2021
33692861 (PubMed )
Supplement: Supplementary_Data.pdf
Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer.
Kane AM et al.
Neoplasia (new York, N.y.), 2020
31935636 (PubMed )
Supplement: mmc2.xlsx › Sheet1
Clinical and biological significance of adamantinomatous craniopharyngioma with CTNNB1 mutation.
Hara T et al.
Journal of Neurosurgery, 2019
Select a paper to view details